Literature DB >> 8043122

P-values, survival analyses and phase II trials.

P Fayers.   

Abstract

Mesh：

Year:  1994        PMID： 8043122      PMCID： PMC1969438          DOI： 10.1038/bjc.1994.232

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  1 in total

1.  A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.

Authors:  A S Jones; D E Phillips; J A Cook; T R Helliwell
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.